← All organizations

BioDelivery Sciences International

For profitWebsite ↗

Also known as: BDSI | BioDelivary Sciences Internantional, Inc. | BioDelivery Sciences International

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

Jun 20, 2022

Acquired by Collegium Pharmaceutical, Inc. on Feb 14, 2022

Timeline

1990s

Jul 1, 1997
BioDelivery Sciences International— Founded

2010s

Jun 6, 2014
buprenorphine— NDA Secondary Org
Jun 6, 2014
naloxone— Marketing Organization

2020s

Feb 14, 2022
Collegium Pharmaceutical, Inc.— Acquired By

Drugs by trial phase (6 distinct, 19 trials)

Phase 4 (1 own, 0 via acquisition)

buprenorphine

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (5)

Recent trials (28)

NCT05419297CollaboratorPhase 4Jun 20, 2022
NCT03996694Lead sponsorPhase 1Jul 3, 2019
NCT02643251Lead sponsorPhase 2Dec 1, 2015
NCT02516436Lead sponsorPhase 3Aug 3, 2015
NCT02355158Lead sponsorPhase 2Jun 1, 2014
NCT02068027Lead sponsorPhase 2Mar 1, 2014
NCT01871285Lead sponsorPhase 2Jun 1, 2013
NCT01755546Study directorPhase 3Dec 1, 2012
NCT01755546Lead sponsorPhase 3Dec 1, 2012
NCT01713803Lead sponsorPhase 3Oct 19, 2012
NCT01675167Study directorPhase 3Sep 1, 2012
NCT01675167Lead sponsorPhase 3Sep 1, 2012
NCT01633944Lead sponsorPhase 3Aug 1, 2012
NCT01666119Lead sponsorPhase 2Aug 1, 2012
NCT01431742Study chairPhase 3Jul 1, 2012

Details

Founded: Raleigh, NC, US Jul 1, 1997
Last known activity: Jun 20, 2022